← Back to Patent Explorer
US4499183A Expired / Lapsed US ⏱️ 0.0 years remaining

Detecting intracellular antigens in swelled and fixed cells with labeled antibody

Assignee: Ortho Clinical Diagnostics Inc
•
Filing: 1982-12-21
•
Granted: 1985-02-12
•
Expires: 2002-12-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Methods and reagent kits for the detection of intracellular antigens such as TdT and antinuclear antibodies. The methods involve swelling the cells with a hypotonic solution for increasing the localization of large molecular weight substances such as antibodies at intracellular antigenic sites, fixing the cells and reacting them with antibodies specific for the intracellular antigen to be detected. The cells are then further reacted with labeled antibody specific for the first antibody, washed to remove unreacted antibodies and the presence of label detected whereby the presence or absence of the intracellular antigen may be determined.

Inventors

  • 👤 Daniel J. Sujansky
  • 👤 Martha W. Rancourt

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 12:42
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/573; G01N33/569; G01N33/56966; Y; Y10; Y10S; Y10S435/00; Y10S435/81; Y10S435/962; Y10S435/975; Y10S436/00; Y10S436/804; Y10S436/805; Y10S436/807; Y10S436/808

Claims Analysis

Total Claims: 30
Claim 1
Independent Claim 115 words
A method of detecting intracellular antigens selected from the group consisting of hormones, enzymes, DNA, RNA, immunoglobulins, drugs, and organelle associated antigens in whole cells comprising the steps of contacting the cells with a hypotonic solution whereby the cells swell in size but step; fixing the cells whereby the cell membranes are rigidized and water is removed; hydrating and reacting the cells under conditions permitting immunological reactions with specific for the antigen to be detected and having a detectable label; washing to remove antibodies which have not reacted with the antigen to be detected; and detecting the presence of said label whereby the absence or presence of the antigen to be detected may be determined.
Claim 2
Independent Claim 115 words
A method of detecting intracellular antigens selected from the group consisting of hormones, enzymes, DNA, RNA, immunoglobulins, drugs, and organelle associated antigens in whole cells comprising the steps of contacting the cells with a hypotonic solution whereby the cells swell in size but step; fixing the cells whereby the cell membranes are rigidized and water is removed; hydrating and reacting the cells under conditions permitting immunological reactions with specific for the antigen to be detected and having a detectable label; washing to remove antibodies which have not reacted with the antigen to be detected; and detecting the presence of said label whereby the absence or presence of the antigen to be detected may be determined.
Claim 3
Dependent Claim 26 words
The method as provided in claim 1 wherein the label is selected from the group consisting of fluorophores, radioisotopes, enzymes, metal particles and light scattering substances.
Claim 4
Dependent Claim 35 words
The method as provided in claim 1 wherein the label is an enzyme and before the detecting step, substrate is added whereby detectable product is produced by the action of said enzyme on said substrate.
Claim 5
Dependent Claim 57 words
The method as provided in claim 1 wherein the detecting step is accomplished by placing the cells after the washing step into a flow cytometry apparatus which hydrodynamically focuses the cells, illuminates the cells by a focused light source, and detects the presence of said label by detecting the resultant altered light characteristics occasioned by said label.
Claim 6
Dependent Claim 15 words
The method as provided in claim 1 wherein the antigen to be detected is TdT.
Claim 7
Dependent Claim 14 words
The method as provided in claim 5 wherein the antibody is rabbit anti-TdT antibody.
Claim 8
Independent Claim 153 words
A method for determining the presence of antibodies specific for intracellular related antigens in a sample comprising the steps of: providing cells having intracellular antigens with which the antibodies to be detected can react; contacting said cells with a hypotonic swelling solution whereby the cells swell in size but substantially do not lyse prior to the completion of the detecting step; fixing the cells by further contacting said cells with a fixing solution whereby the cell membrane is rigidized and water is removed; hydrating and reacting the cells with the sample containing the antibodies to be detected; further reacting the cells with a second antibody having a detectable label attached thereto and specific for the antibodies to be detected; and detecting the presence of label for only those labeled antibodies which have reacted with the antibodies to be determined and which have in turn have reacted with the intracellular antigens of said cells.
Claim 9
Independent Claim 153 words
A method for determining the presence of antibodies specific for intracellular related antigens in a sample comprising the steps of: providing cells having intracellular antigens with which the antibodies to be detected can react; contacting said cells with a hypotonic swelling solution whereby the cells swell in size but substantially do not lyse prior to the completion of the detecting step; fixing the cells by further contacting said cells with a fixing solution whereby the cell membrane is rigidized and water is removed; hydrating and reacting the cells with the sample containing the antibodies to be detected; further reacting the cells with a second antibody having a detectable label attached thereto and specific for the antibodies to be detected; and detecting the presence of label for only those labeled antibodies which have reacted with the antibodies to be determined and which have in turn have reacted with the intracellular antigens of said cells.
Claim 10
Dependent Claim 35 words
The method as provided in claim 7 wherein the label is an enzyme and before the detecting step, substrate is added whereby detectable product is produced by the action of said enzyme on said substrate.
Claim 11
Dependent Claim 26 words
The method as provided in claim 7 wherein the label is selected from the group consisting of fluorophores, radioisotopes, enzymes, metal particles and light scattering substances.
Claim 12
Dependent Claim 41 words
The method as provided in claim 9 wherein the detecting step further comprises washing said cells to remove unreacted labeled antibodies whereby detection of only those labeled antibodies which have reacted with the antibqdies specific for the intracellular antigens is realized.
Claim 13
Dependent Claim 60 words
The method as provided in claim 10 wherein the detecting step is accomplished by adding said sample to flow cytometry apparatus which hydrodynamically focuses the cells, passes the cells past a focused light source, and detects the label by the resultant altered light characteristics of the cells whereby the presence of antibodies specific for intracellularly related antigens may be determined.
Claim 14
Dependent Claim 66 words
A reagent test kit for determining the presence of intracellular TdT by detecting an antibody associated label comprising in separate containers: (a) first antibody specific for TdT; (b) FITC labeled second antibody specific for the first antibody; and (c) swelling solution having a hypotonicity adjusted to swell the cells but not substantially lyse the cells prior to completion of the label detecting step of the test.
Claim 15
Dependent Claim 66 words
A reagent test kit for determining the presence of intracellular TdT by detecting an antibody associated label comprising in separate containers: (a) first antibody specific for TdT; (b) FITC labeled second antibody specific for the first antibody; and (c) swelling solution having a hypotonicity adjusted to swell the cells but not substantially lyse the cells prior to completion of the label detecting step of the test.
Claim 16
Dependent Claim 50 words
The reagent kit as provided in claim 12 further comprising: (a) control antibodies with which the reactivity of the first antibody can be monitored; and (b) coating and wash buffers in a form selected from the group consisting of preweighed dry chemicals for addition to water and premixed, aqueous solutions.
Claim 17
Dependent Claim 59 words
A reagent test kit for determining the presence of antinuclear antibodies comprising in separate containers: (a) cells having nuclear antigens with which the antinuclear antibodies can react; (b) FITC labled antibodies specific for the antinuclear antibodies; and (c) swelling solution having a hypotonicity adjusted to swell the cells but not substantially lyse cells prior to completion of the test.
Claim 18
Dependent Claim 59 words
A reagent test kit for determining the presence of antinuclear antibodies comprising in separate containers: (a) cells having nuclear antigens with which the antinuclear antibodies can react; (b) FITC labled antibodies specific for the antinuclear antibodies; and (c) swelling solution having a hypotonicity adjusted to swell the cells but not substantially lyse cells prior to completion of the test.
Claim 19
Independent Claim 91 words
A method for determining the presence of, in a sample containing cells, antibodies which are specific for and have reacted with intracellularly located antigens comprising the steps of providing a sample containing cells suspected of having intracellular antibodies which have previously reacted with intracellularly located antigens; contacting said cells with a hypotonic swelling solution whereby the cells swell in size; reacting said swollen cells with labeled antibodies specific for the antibodies whose presence is to be determined whereby an antibody complex is formed; detecting the presence of only labeled antibody complexes.
Claim 20
Independent Claim 91 words
A method for determining the presence of, in a sample containing cells, antibodies which are specific for and have reacted with intracellularly located antigens comprising the steps of providing a sample containing cells suspected of having intracellular antibodies which have previously reacted with intracellularly located antigens; contacting said cells with a hypotonic swelling solution whereby the cells swell in size; reacting said swollen cells with labeled antibodies specific for the antibodies whose presence is to be determined whereby an antibody complex is formed; detecting the presence of only labeled antibody complexes.
Claim 21
Dependent Claim 26 words
The method as provided in claim 15 wherein the label is selected from the group consisting of fluorophores, radioisotopes, enzymes, metal particles and light scattering substances.
Claim 22
Dependent Claim 35 words
The method as provided in claim 15 wherein the label is an enzyme and before the detecting step, substrate is added whereby detectable product is produced by the action of said enzyme on said substrate.
Claim 23
Independent Claim 138 words
A method for detecting intracellular antigens selected from the group consisting of hormones, enzymes, DNA, RNA, immunoglobulins, drugs and organelle associated antigens in whole cells comprising the steps of contacting the cells with a hypotonic solution whereby the cells swell in size but substantially do not lyse prior to completion of the detecting step; fixing the cells whereby the cell membranes are rigidized and water is removed; hydrating and reacting the cells under conditions permitting immunological reactions with a first antibody specific for the antigen to be detected; further reacting said cells with a second antibody specific for said first antibody and having a detectable label associated therewith; washing to remove antibodies which have not reacted immunologically; and detecting the presence of said label whereby the absence or presence of the antigen to be detected may be determined.
Claim 24
Independent Claim 138 words
A method for detecting intracellular antigens selected from the group consisting of hormones, enzymes, DNA, RNA, immunoglobulins, drugs and organelle associated antigens in whole cells comprising the steps of contacting the cells with a hypotonic solution whereby the cells swell in size but substantially do not lyse prior to completion of the detecting step; fixing the cells whereby the cell membranes are rigidized and water is removed; hydrating and reacting the cells under conditions permitting immunological reactions with a first antibody specific for the antigen to be detected; further reacting said cells with a second antibody specific for said first antibody and having a detectable label associated therewith; washing to remove antibodies which have not reacted immunologically; and detecting the presence of said label whereby the absence or presence of the antigen to be detected may be determined.
Claim 25
Dependent Claim 26 words
The method as provided in claim 18 wherein the label is selected from the group consisting of fluorophores, radioisotopes, enzymes, metal particles and light scattering substances.
Claim 26
Dependent Claim 35 words
The method as provided in claim 18 wherein the label is an enzyme and before the detecting step, substrate is added whereby detectable product is produced by the action of said enzyme on said substrate.
Claim 27
Dependent Claim 57 words
The method as provided in claim 18 wherein the detecting step is accomplished by placing the cells, after the washing step, into a flow cytometry apparatus which hydrodynamically focuses the cells, illuminates the cells by a focused light source, and detects the presence of said label by detecting the resultant altered light characteristics occasioned by said label.
Claim 28
Dependent Claim 15 words
The method as provided in claim 18 wherein the antigen to be detected is TdT.
Claim 29
Dependent Claim 15 words
The method as provided in claim 22 wherein the first antibody is rabbit anti-TdT antibody.
Claim 30
Dependent Claim 15 words
The method as provided in claim 23 wherein the second antibody is goat anti-rabbit antibody.

References Cited (Backward Citations)

US3864212A Cited
US4296201A Cited
US4307189A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-02-12 1988-08-13 1989-02-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-02-12 1992-08-13 1993-02-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-02-12 1996-08-13 1997-02-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag